This article was originally published in Start Up
Nightingale-EOS Ltd.'s Beam Profile Reflectometry technology evaluates coatings on medical devices by measuring the interference effects caused by the interaction of light reflecting from the coating surface with that from the substrate surface. The company's first focus is on implanted cardiac devices, primarily drug-eluting stents, where BPR can measure the concentration of the drug within the film of the coating.
You may also be interested in...
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Inflammation: A Hot Space Gets Complicated," features profiles of CellAct Pharma, Kineta and Lycera. Plus these Start-Ups Across Health Care: BioLeap, Integrated Diagnostics, Nightingale-EOS, SBIO, Spirus Medical and Varix Medical.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.